Cellular Aging, Telomere Length, and Neuropsychiatry The ticking biological clock and how it relates to brain illnesses

#brainhealth #neuropsychiatry #wellness #aging #telomeres #cellularhealth #brain #brainhealthmatters #mentalhealth #neuroinflammation #neuroscience

Cellular Aging, Telomere Length, and Neuropsychiatry

The complexity of neurological and psychiatric diseases often results from multifactorial and heterogeneous pathophysiology. Therefore, precision medicine approaches are needed to screen, diagnose, and treat these diseases. One potential avenue of precision medicine research is the study of cellular aging and telomere length, which have been linked to various neuropsychiatric diseases, including depression, anxiety, OCD, tic disorders, and PTSD. There is some interplay here between cellular aging, telomere length, and Neuropsychiatry from a systems biology perspective —and we will look at some aspects of the through neuroendocrine and neuroimmune eyes.

Shortened leukocyte telomere length (LTL) is associated with certain neuropsychiatric diseases, such as depression, anxiety, OCD, certain tic disorders, and PTSD?—it predicts mortality.

General Physiology and Disordered Physiology (Aging and otherwise)?

Cellular aging is a natural process where cells change over time, and this can affect their function and viability. Telomere length, the protective caps at the ends of chromosomes that shorten with each cell division, is a well-known indicator of cellular aging. Telomere length reflects the mitotic history of a cell and its cumulative exposure to inflammation, oxidation, and telomerase availability (the enzyme known to repair it —something not common in ready supply in humans. Critically short telomeres can cause cells to undergo senescence, apoptosis (programmed cell death), or genomic instability, leading to adverse health outcomes. Emerging evidence suggests that shortened leukocyte telomere length (LTL) is associated with certain neuropsychiatric diseases, such as depression, anxiety, OCD, certain tic disorders, and PTSD, —which predicts mortality.

Inflammation is a critical mediator

Inflammation is a critical mediator of many neuropsychiatric diseases, and proinflammatory cytokines play a crucial role in cellular aging and telomere length. Proinflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), are known to accelerate cellular aging and shorten telomere length. Inflammatory markers are associated with shorter LTL in neuropsychiatric diseases, including depression and PTSD. Additionally, studies have shown that bilirubin, a byproduct of heme catabolism with potent anti-inflammatory properties, is associated with longer LTL and a lower risk of various neuropsychiatric diseases, including depression and schizophrenia.?

See my recent essay on Bilirubin and the Brain.

Precision Medicine Approaches in Neuropsychiatry

Precision medicine approaches in Neuropsychiatry could provide a way to screen, diagnose, and treat patients based on their specific clinical, genetic, and biological characteristics and risk factors. A systems biology approach can help identify patient-specific factors contributing to understanding the role of cellular aging and telomere length in Neuropsychiatry. Precision medicine approaches could involve genetic and biomarker screening to tailor treatment strategies to an individual’s needs. One example is the use of blood-based biomarkers to predict treatment responses in depression —not quite ready for primetime at the moment, but oh, are we so close, with some already-available tests helping guide treatment. Additionally, interventions that reduce inflammation and oxidative stress, such as exercise and mindfulness-based stress reduction, have been found to increase telomerase activity and lengthen telomeres.?

See my recent repost of the article demonstrating the positive effects of exercise on depression.

The potential of systems biology to identify patient-specific factors contributing to understanding cellular aging and telomere length role in Neuropsychiatry highlights the interplay between the nervous, endocrine, and immune systems in this context. Cellular aging and telomere length are crucial in general physiology and neuropsychiatric diseases. Proinflammatory cytokines and inflammation accelerate cellular aging and shorten telomere length, while bilirubin has been found to have anti-inflammatory properties and is associated with longer telomere length. Precision medicine approaches like genetic and biomarker screening can tailor treatment strategies to an individual’s needs. Additionally, interventions that reduce inflammation and oxidative stress, such as exercise and mindfulness-based stress reduction, have been found to increase telomerase activity and lengthen telomeres.

Future research directions on cellular aging, telomere length, and Neuropsychiatry from a systems biology perspective include investigating the mechanisms contributing to the relationship between inflammation, cellular aging, and telomere length in neuropsychiatric diseases. Moreover, understanding the role of telomerase in Neuropsychiatry and the effects of treatments on telomerase activity and telomere length could lead to new treatment targets. It is also essential to investigate the potential role of telomere length in predicting the risk of developing neuropsychiatric diseases, cognitive decline, and dementia.

“findings show that shorter telomeres can be linked to multiple changes in the brain associated with dementia” —(Topiwala, A et al, 2023)

The potential of systems biology to identify patient-specific factors contributing to understanding cellular aging and telomere length role in Neuropsychiatry highlights the interplay between the nervous, endocrine, and immune systems in this context. Cellular aging and telomere length are crucial in general physiology and neuropsychiatric diseases. Proinflammatory cytokines and inflammation accelerate cellular aging and shorten telomere length, while bilirubin has anti-inflammatory properties and is associated with longer telomere length. Precision medicine approaches like genetic and biomarker screening can tailor treatment strategies to an individual’s needs. Future research directions could lead to a better understanding of the mechanisms underlying the relationship between cellular aging, telomere length, neuropsychiatric diseases, and the development of new treatment targets.

References:

1. Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198.
2. Mathur MB, Epel E, Kind S, Desai M, Parks CG, Sandler DP, Khazeni N. Perceived stress and telomere length: a systematic review, meta-analysis, and methodologic considerations for advancing the field. Brain Behav Immun. 2016;54:158-169.
3. Malan S, Hemmings S, Kidd M, Martin L. The role of oxidative stress and inflammation in stress-induced cognitive dysfunction in humans. Stress. 2011;14(1):1-13.
4. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: do stress and depression accelerate cell aging?. Depress Anxiety. 2010;27(4):327-338.
5. Kiecolt-Glaser JK, Glaser R. Psychological stress, telomeres, and telomerase. Brain Behav Immun. 2010;24(4):529-530.
6. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198.
7. Kiecolt-Glaser JK, Glaser R. Psychological stress, telomeres, and telomerase. Brain Behav Immun. 2010;24(4):529-530.
8. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004;101(49):17312-17315.
9. Hodes RJ, Sierra F, Austad SN, et al. Disease drivers of aging. Ann N Y Acad Sci. 2016;1386(1):45-68.
10. Topiwala, A., Nichols, T. E., Williams, Z. J., Robinson, E. C., Alfaro-Almagro, F., Taschler, B., Wang, C., Nelson, C. P., Miller, K. L., Codd, V., Samani, N. J., & Smith, S. M. (2023). Telomere length and brain imaging phenotypes in UK Biobank.?PLOS ONE,?18(3), e0282363. https://doi.org/10.1371/journal.pone.0282363
11. Tyrka AR, Parade SH, Price LH, Kao HT, Porton B, Philip NS, et al. Alterations of mitochondrial DNA copy number and telomere length with early adversity and psychopathology. Biol Psychiatry. 2016;79(1):78-86.
12. Lindqvist D, Epel ES, Mellon SH, et al. Psychiatric disorders and leukocyte telomere length: underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev. 2015;55:333-364.
13. Wium-Andersen MK, ?rsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73,131 individuals. JAMA Psychiatry. 2013;70(2):176-184.
14. Drury SS, Theall K, Gleason MM, et al. Telomere length and early severe social deprivation: linking early adversity and cellular aging. Mol Psychiatry. 2012;17(7):719-727.
15. Picard M, McEwen BS. Psychological stress and mitochondrial function: a conceptual framework. Psychosom Med. 2018;80(2):126-140.
16. Sen A, Nelson TJ, Alkon DL. Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase Cε. J Biol Chem. 2013;288(48):27909-27920.
17. Wolkowitz OM, Mellon SH, Epel ES, et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry. 2012;17(2):164-172.